Three New Units to Focus on Convergence and New Opportunities
NEW BRUNSWICK, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced a series of organizational changes to sharpen its focus on opportunities outside its traditional areas of interest and in the growing intersections of health care. These include the creation of a new strategy and growth organization and two new business operating groups. The changes are designed to accelerate growth for Johnson & Johnson by building on the unique strengths afforded by the Company's broad base of businesses and decentralized structure.
A new Office of Strategy and Growth will identify opportunities for future growth that are distinct from those being pursued by the Company's existing businesses; a Surgical Care Group will focus on advancing technologies, solutions and services to enhance patient care in the surgical setting; and a Comprehensive Care Group will create portfolios to address some of the world's most chronic and pervasive conditions, such as metabolic disorders, through the convergence of technologies, products and services.
"These decisions recognize that a new environment is emerging in human health and well-being," said William C. Weldon, Chairman and Chief Executive Officer of Johnson & Johnson. "They reflect our assessment of the best way for us to capture and develop the opportunities associated with those changes and they capitalize on the unique, broadly-based, decentralized approach of Johnson & Johnson."
The Office of Strategy and Growth will be led by Nicholas J. Valeriani,
currently Worldwide Chairman, Medical Devices and Diagnostics. The new
office will identify new growth opportunities distinct from existing
pursuits that are strategic fits for Johnson & Johnson and that have the
potential for significant impact on human health. As part of his role, Mr.
Valeriani will assume responsibility for the Johnson & Johnson Development
|SOURCE Johnson & Johnson|
Copyright©2007 PR Newswire.
All rights reserved